JPMorgan Chase & Co’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $208K | Sell |
18,467
-137,029
| -88% | -$1.54M | ﹤0.01% | 4437 |
|
|
2025
Q1 | $886K | Buy |
155,496
+155,375
| +128,409% | +$886K | ﹤0.01% | 3725 |
|
|
2024
Q4 | $1.19K | Sell |
121
-15,184
| -99% | -$149K | ﹤0.01% | 5657 |
|
|
2024
Q3 | $125K | Buy |
15,305
+504
| +3% | +$4.11K | ﹤0.01% | 4640 |
|
|
2024
Q2 | $198K | Sell |
14,801
-253
| -2% | -$3.38K | ﹤0.01% | 4278 |
|
|
2024
Q1 | $698K | Sell |
15,054
-11,720
| -44% | -$544K | ﹤0.01% | 3771 |
|
|
2023
Q4 | $1.81M | Buy |
26,774
+5,908
| +28% | +$399K | ﹤0.01% | 3199 |
|
|
2023
Q3 | $1.51M | Buy |
20,866
+1,388
| +7% | +$100K | ﹤0.01% | 3176 |
|
|
2023
Q2 | $1.45M | Sell |
19,478
-7,407
| -28% | -$551K | ﹤0.01% | 3216 |
|
|
2023
Q1 | $1.43M | Sell |
26,885
-3,946
| -13% | -$210K | ﹤0.01% | 3243 |
|
|
2022
Q4 | $2.08M | Buy |
30,831
+10,968
| +55% | +$741K | ﹤0.01% | 2935 |
|
|
2022
Q3 | $2.48M | Buy |
19,863
+6,332
| +47% | +$790K | ﹤0.01% | 2780 |
|
|
2022
Q2 | $1.29M | Sell |
13,531
-53,872
| -80% | -$5.13M | ﹤0.01% | 3302 |
|
|
2022
Q1 | $10.9M | Buy |
67,403
+37,474
| +125% | +$6.04M | ﹤0.01% | 1970 |
|
|
2021
Q4 | $9.95M | Buy |
29,929
+29,253
| +4,327% | +$9.72M | ﹤0.01% | 2104 |
|
|
2021
Q3 | $313K | Buy |
+676
| New | +$313K | ﹤0.01% | 4198 |
|